Associate Director, Immunology, Cardiovascular & Neuroscience (ICVN), Medical Engagement Excellence at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Biotechnology, HealthcareIndustries

Requirements

Report to the Senior Director, US Medical Engagement Excellence within the MedEngageX team
Experience or expertise in Immunology, Cardiovascular & Neuroscience (ICVN) therapeutic areas
Ability to partner across matrix organizations, including Worldwide/US medical teams, Field Medical (FM) teams, and Medical Engagement Leads (MELs)
Knowledge of field medical strategies, narratives, operational/reporting systems (e.g., customer relationship management, content management, medical insights platforms)
Skills in optimizing medical insight quality, analysis, and communications, including support for Fast Insight Review (FIRe) teams
Capability to coordinate study support, analytics, and value demonstration for priority studies
Experience maintaining connectivity with market Field Medical personnel and stakeholders
Ability to proactively identify and escalate opportunities for optimization, standardization, and efficiency
Potential responsibility for managing team project/operational support (e.g., graduates, Fellows, interns)
Familiarity with Medical Communications Working Groups, Assets Indications Management (AIMS) teams, Medical Communication Topics (MCTs) in InterAct, and Insight Categories in MEDsights

Responsibilities

Inform development of ICVN field medical strategies and narratives, leveraging medical insights to represent market FM teams
Partner across the matrix to ensure effective FM communications and engagement
Ensure ICVN input is maintained in FM operational/reporting systems, including customer relationship management, content management, and medical insights platforms
Optimize medical insight quality, analysis, and communications, including operational support for Worldwide and Markets’ Fast Insight Review (FIRe) teams
Coordinate MedEngageX efforts to ensure optimal FM Study Support within and across ICVN, including analytics and value demonstration for Tier 1 priority studies
Maintain connectivity with market Field Medical personnel and stakeholders, ensuring feedback informs and aligns MedEngageX activities with market needs
Proactively outreach and partner across MedEngageX TA teams to identify and escalate opportunities to optimize and standardize deliverables and ways of working
Participate actively in assigned Medical Communications Working Groups or those downstream from AIMS teams
Ensure FM interests and insights are represented in global/US Field Medical plans supporting overall medical strategies
Ensure globally consistent and locally relevant pull-through of medical strategies
Maintain alignment and implementation of Medical Communication Topics (MCTs) for stakeholder interaction documentation in InterAct and Insight Categories in MEDsights
Partner for priority congresses, ensuring FM interests and activities are represented and coordinated
May manage team project/operational support (e.g., graduates, Fellows, interns)

Skills

Medical Strategy

Field Medical

Healthcare Professional Education

Therapeutic Area Strategy

Compliance

Medical Engagement

ICVN

Immunology

Cardiovascular

Neuroscience

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free